These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7459202)

  • 1. Oxytocin potentiation with low dose intravenous prostaglandin E2 in the management of therapeutic abortion.
    Beazley JM; Clarke JF
    Br J Clin Pract; 1980; 34(11-12):329-33. PubMed ID: 7459202
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interruption of the second and third trimester of a normal and missed pregnancy by extraamnial prostaglandin E administration combined with oxytocin infusion (author's transl)].
    Havránek F; Jungmannová C
    Cesk Gynekol; 1979 Apr; 44(3):179-82. PubMed ID: 445588
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin E2 vaginal suppositories for therapeutic abortion.
    Newman C; Bailey CD; Ellinas SP; Anderson GG
    Adv Plan Parent; 1975; 10(1):34-8. PubMed ID: 1164986
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intravenous prostaglandin E2 in inductions of high risk labor].
    Iglesias E; de la Fuente P; González A; Olaizola JI; Alvarez Charines E; Garcia S Elvira JI
    Acta Obstet Ginecol Hisp Lusit; 1980 Apr; 28(4):261-80. PubMed ID: 7435172
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elective inducing of labor with protaglandin E2 tablets].
    Thiery M; de Hemptinne D; Yo Le Sian A; Derom R; Martens G; Van Kets H; Amy JJ
    Verh K Acad Geneeskd Belg; 1974; 36(5-6):219-32. PubMed ID: 4619260
    [No Abstract]   [Full Text] [Related]  

  • 7. The contraction stress test: A comparison of buccal and intravenous oxytocin and oral prostaglandin E2.
    Boehm FH; Killam AP; Duncan L
    J Tenn Med Assoc; 1979 Dec; 72(12):890-2. PubMed ID: 522461
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of extra- and intra-amniotic prostaglandins for therapeutic abortion.
    Fraser IS; Brash JH
    Obstet Gynecol; 1974 Jan; 43(1):97-103. PubMed ID: 4808969
    [No Abstract]   [Full Text] [Related]  

  • 9. [Induced labor. A comparative study of prostaglandin gel placed in the cervix and parenteral oxytocin].
    Lindholm P
    Ugeskr Laeger; 1981 Mar; 143(14):878-81. PubMed ID: 7292661
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic abortion employing the synergistic action of extra-amniotic prostaglandin E 2 and an intravenous infusion of oxytocin.
    Morewood GA
    J Obstet Gynaecol Br Commonw; 1973 May; 80(5):473-5. PubMed ID: 4712943
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandin-oxytocin enhancement and potentiation and their clinical applications.
    Gillespie A
    Br Med J; 1972 Jan; 1(5793):150-2. PubMed ID: 5007843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine rupture with the use of vaginal prostaglandin E2 suppositories.
    Sandler RZ; Knutzen VK; Milano CM; Gleicher N
    Am J Obstet Gynecol; 1979 Jun; 134(3):348-9. PubMed ID: 453268
    [No Abstract]   [Full Text] [Related]  

  • 13. Termination of pregnancy in patients with missed abortion and intrauterine dead fetuses by a single intracervical application of prostaglandin E2 in viscous gel.
    Ekman G; Forman A; Ulmsten U; Wingerup L
    Zentralbl Gynakol; 1980; 102(4):219-22. PubMed ID: 7467962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of labor with prostaglandins after previous cesarean section].
    Jelínek J; Páral V; Roztocil A; Pilka L; Huvar I; Hykel P
    Zentralbl Gynakol; 1993; 115(3):109-12. PubMed ID: 8465621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the potentiating effect of prostaglandin E2 and oxytocin to induced second trimester abortion.
    Alderman B; Thelwall-Jones H
    J Obstet Gynaecol Br Commonw; 1973 Nov; 80(11):1021-4. PubMed ID: 4752984
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].
    Hidar S; Fekih M; Chaïeb A; Bibi M; Mellouli R; Khaïri H
    J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induced abortion by extraamniotic intrauterine instillation of prostaglandin E2].
    Göretzlehner G; Rudolf K; Klausch B; Kruse HJ
    Dtsch Gesundheitsw; 1974 Apr; 29(17):769-71. PubMed ID: 4459062
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-balloon instillation device for second-trimester abortion. Outcome in 340 consecutive cases.
    Abramovici H; Bornstein J; Ben-David Y; Yishai D; Rofe A; Atad J
    J Reprod Med; 1995 Jan; 40(1):56-62. PubMed ID: 7722978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
    Owen J; Hauth JC
    Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reaction to extra-amniotic prostaglandin E2.
    McNicol E; Gray H
    Br J Obstet Gynaecol; 1977 Mar; 84(3):229-30. PubMed ID: 843502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.